Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
May 8, 2024 6:31 PM 2 min read

Bill Hwang's Trial Begins Over Archegos Fund Collapse: What To Expect

by Michael Cohen Benzinga Editor
Follow
FlipboardIcon version of the Flipboard logo

The criminal racketeering trial of Bill Hwang, founder of Archegos Capital Management, began on Wednesday in New York. Hwang and his deputy face charges related to an alleged stock manipulation scheme that led to the fund’s dramatic collapse in 2021, according to Reuters.

What Happened: The trial began with screening potential jurors, who will undergo a series of questioning rounds to determine their suitability for the anticipated eight-week trial.

The trial will center on the implosion of Hwang’s family investment firm, which prosecutors claim led to shareholder losses exceeding $100 billion. The prosecution contends that Hwang covertly built up positions in several stocks using derivatives, driving up their prices, and then misrepresented these holdings to sustain relationships with international banks.

See Also: Xi Jinping Says He Would ‘Never Forget’ NATO’s Bombing Of Chinese Embassy 25 Years Ago: ‘Will Never Allow

Hwang and his deputy, Patrick Halligan, face charges of racketeering conspiracy. Hwang also faces 10 counts of fraud and market manipulation, while Halligan faces two counts of fraud. Both have pleaded not guilty and are expected to argue that the prosecutors’ market manipulation theory is novel and nonsensical, Reuters reported.

Archegos Capital Management’s downfall in March 2021 was linked to Hwang’s strategy of utilizing total return swaps to secure substantial positions in select stocks without direct ownership. The firm engaged in heavy borrowing, amassing $36 billion in assets and exposure to equity worth $160 billion.

Declines in stock values precipitated margin calls that Archegos failed to satisfy, resulting in major financial damage to both the fund and its creditors, such as Credit Suisse, which has since merged into UBS Group AG (NYSE:UBS).

Why It Matters: The collapse of Archegos Capital Management had a significant impact on the financial markets.

In May 2021, it was reported George Soros bought millions’ worth of stocks that had taken a hit due to the collapse. This investment by Soros signaled his confidence in the potential recovery of these affected stocks.

Read Next: Trump Says If Supreme Court Decides President Doesn’t Get Immunity Then Biden ‘Will Be Prosecuted For All‘

This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.

Image created using artificial intelligence via Midjourney.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
NewsTopicsLegalAI Generatedbenzinga neuro
UBS Logo
UBSUBS Group AG
$38.72-0.30%
Overview
UBS Logo
UBSUBS Group AG
$38.72-0.30%
Overview
Comments
Loading...